Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ADMA Biologics
AddedFeb 19, 2024
UpdatedJul 4, 2026
ADMA Biologics

ADMA Biologics

Public

US-based ADMA Biologics develops plasma biologics for treating and preventing infectious diseases.

HQ
Ramsey, NJ, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Founded in Ramsey, United States, ADMA Biologics is dedicated to developing plasma-derived biologics aimed at treating and preventing infectious diseases. The company's core mission is to enhance the lives of immunocompromised individuals and patients at risk for certain infections through innovative immunotechnology. ADMA Biologics offers a portfolio of FDA-approved immune globulin products and utilizes a proprietary microneutralization assay to measure neutralizing antibody levels.

Notable figures associated with ADMA Biologics include experienced professionals in the biopharmaceutical industry and key investors who have supported its mission. The company has achieved significant milestones, including the approval and commercialization of its immune globulin products. ADMA Biologics' impact is evident in its contribution to improving patient outcomes and advancing the field of plasma-derived therapeutics.

ADMA Biologics - Similar Companies

Biomat USA logo

Biomat USA

grifolsplasma.com

AIM Immunotech logo

AIM Immunotech

aimimmuno.com

Adimab logo

Adimab

adimab.com

MacroGenics logo

MacroGenics

macrogenics.com

Adaptive Biotechnologies logo

Adaptive Biotechnologies

ADS Biotechnology logo

ADS Biotechnology

Direct Biologics logo

Direct Biologics

Idbiologics logo

Idbiologics

idbiologics.com

IGM Biosciences logo

IGM Biosciences

igmbio.com

Circle Biologics logo

Circle Biologics

BioClonetics Immunotherapeutics logo

BioClonetics Immunotherapeutics

ProThera Biologics logo

ProThera Biologics

Critical Biologics logo

Critical Biologics

HI-Bio logo

HI-Bio

hibio.com

Whitehawk Therapeutics logo

Whitehawk Therapeutics

aadibio.com

ADMA Biologics - Quick Facts

Who are ADMA Biologics' competitors?

Companies similar to ADMA Biologics include Biomat USA, AIM Immunotech, Adimab and MacroGenics.

When was ADMA Biologics founded?

ADMA Biologics was founded in 2004.

Where is ADMA Biologics' headquarters located?

ADMA Biologics' headquarters is located in Ramsey, NJ, US.

When was ADMA Biologics' last funding round?

ADMA Biologics' most recent funding round was for $135M (USD) in December 2023.

How much has ADMA Biologics raised to-date?

As of Dec 18, 2023, ADMA Biologics has raised a total of $742.4M (USD).

How many employees does ADMA Biologics have?

ADMA Biologics has 617 employees as of Feb 6, 2024.

ADMA Biologics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Plasma Biologics
Tags
  • Biotech
  • Healthtech
Unique IDs
  • secCik: 0001368514
  • ticker: ADMA
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 18 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 6700Holding And Other Investment Offices
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research